Navigation Links
PEAK Surgical, Inc. Closes $21 Million Series C Financing
Date:2/4/2008

- Joyce Erony Joins Board of Directors -

PALO ALTO, Calif., Feb. 4 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that is developing a new category of tissue dissection systems based on a proprietary technology, today announced that it has raised $21 million in a Series C financing led by new investor Signet Healthcare Partners. The company also announced that Joyce Erony, managing director of Signet Healthcare Associates, has joined PEAK Surgical's board of directors. Existing investors Lehman Brothers and Venrock Associates also participated in this financing round.

"The size, valuation and timing of this financing validates the progress we have made in advancing our pulsed plasma technology and developing our flagship product, the PEAK Surgery System," said John Tighe, president and chief executive officer of PEAK Surgical. "This financing allows us to aggressively pursue the development plan and commercialization efforts for our PEAK Surgery System, which we believe represents a quantum leap over surgical instruments in use today and will revolutionize the way surgery is performed. We believe it may have applications in more than 2 million surgical procedures."

The PEAK(TM) Surgery System includes the PEAK PlasmaBlade(TM), a disposable cutting tool that offers the exacting control of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage. PEAK Surgical has filed a pre-market notification (510k) with the U.S. Food and Drug Administration (FDA) for the PEAK Surgery System. The company also has started setting up manufacturing for the PEAK PlasmaBlade and is establishing a national sales force to distribute the device once the 510k has been cleared by the FDA.

"PEAK Surgical has the financial foundation, management team and technology platform in place to ensure rapid development of its next-generation tissue dissection system," Erony said. "We believe PEAK Surgical's pulsed plasma technology has broad applicability across numerous surgical fields and that the PEAK PlasmaBlade may offer a new alternative for surgeons to provide better outcomes for their patients, including reduced scarring and faster recovery."

PEAK Surgical has raised more than $29 million to date in three rounds of private financing.

About PEAK Surgical, Inc.

PEAK Surgical, Inc. is a medical device company that is developing a new category of tissue dissection systems based on a proprietary technology. PEAK's flagship product in development, the PEAK(TM) Surgery System, combines the PULSAR(TM) Generator, which supplies unrivaled pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade(TM), a disposable cutting tool that offers the exacting control of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage. The company is exploring the applicability of this technology across numerous surgical fields, including general, cardiac, gynecologic, plastic and neuro surgery. For more information, please visit http://www.peaksurgical.com.


'/>"/>
SOURCE PEAK Surgical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
2. Synergy Life Science Partners Closes $143M Debut Medical Device Fund
3. MM2 Group Closes Sale for New Fish Oil Product
4. NutraDyne, Inc. Closes Amended Exchange Agreement With Changchun Yongxin Dirui Medical Co., Ltd.
5. MM2 Group Closes $1.1 Million Sale
6. Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares
7. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
8. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
9. Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
10. Nexia Closes Acquisition of Green Endeavors; Landis Salons On Track to Generate Revenues of $2.2 Million in 2007
11. MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology: